Saturday, February 04, 2012

Multiple Myeloma

ADMYRE
An Open Label Phase III Study of Aplidin in Combination with Dexamethasone vs. Dexamathasone Alone in Patients with Relapsed/ Refractory Multiple Myeloma.
CA204-006
A Phase 3, Randomized, Open Label trial of Lenalidomide/dexamethasone With or without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma.

We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.

For more information about the clinical trials listed please go to http://www.clinicaltrials.gov/.